相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ability of soluble ST2 to predict left ventricular remodeling in patients with acute coronary syndrome
Sohyeon Park et al.
HEART AND VESSELS (2022)
Association of Soluble Suppression of Tumorigenicity with No-Reflow Phenomenon and Long-Term Prognosis in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome after Percutaneous Coronary Intervention
Qinyao Zhang et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2021)
Correlation between Levels of Serum Lipoprotein-Associated Phospholipase A2 and Soluble Suppression of Tumorigenicity 2 and Condition of Acute Heart Failure Patients and Their Predictive Value for Prognosis
Jinjin Zhang et al.
JOURNAL OF HEALTHCARE ENGINEERING (2021)
A Novel Paradigm Based on ST2 and Its Contribution towards a Multimarker Approach in the Diagnosis and Prognosis of Heart Failure: A Prospective Study during the Pandemic Storm
Radu-Stefan Miftode et al.
LIFE-BASEL (2021)
Soluble ST2, a biomarker of fibrosis, is associated with multiple risk factors, chronic diseases and total mortality in the OPERA study
Yasmina Filali et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2021)
Differences in biomarker concentrations and predictions of long-term outcome in patients with ST-elevation and non-ST-elevation myocardial infarction
Marcus Hjort et al.
CLINICAL BIOCHEMISTRY (2021)
Comparison of Soluble ST2, Pentraxin-3, Galectin-3, and High-Sensitivity Troponin T of Cardiovascular Outcomes in Patients With Acute Decompensated Heart Failure
Masayoshi Yamamoto et al.
JOURNAL OF CARDIAC FAILURE (2021)
EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients
Thomas Luft et al.
FRONTIERS IN IMMUNOLOGY (2021)
Early Measurement of Blood sST2 Is a Good Predictor of Death and Poor Outcomes in Patients Admitted for COVID-19 Infection
Marta Sanchez-Marteles et al.
JOURNAL OF CLINICAL MEDICINE (2021)
The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2
Liang Chen et al.
CARDIOVASCULAR RESEARCH (2020)
Coronaviruses and the cardiovascular system: acute and long-term implications
Tian-Yuan Xiong et al.
EUROPEAN HEART JOURNAL (2020)
Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review
Maryam Aboughdir et al.
VIRUSES-BASEL (2020)
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
Tao Guo et al.
JAMA CARDIOLOGY (2020)
Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?
Gaetano Zizzo et al.
LANCET RHEUMATOLOGY (2020)
In the eye of the storm: the right ventricle in COVID-19
John F. Park et al.
PULMONARY CIRCULATION (2020)
Coronaviruses and the cardiovascular system: acute and long-term implications
Tian-Yuan Xiong et al.
EUROPEAN HEART JOURNAL (2020)
Serum-soluble ST2 as a novel biomarker reflecting inflammatory status and illness severity in patients with COVID-19
Zhikun Zeng et al.
BIOMARKERS IN MEDICINE (2020)
Clinical and Prognostic Significance of sST2 in Heart Failure JACC Review Topic of the Week
Alberto Aimo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Relationship of soluble ST2 to pulmonary hypertension severity in patients undergoing cardiac resynchronization therapy
Jonathan Beaudoin et al.
JOURNAL OF THORACIC DISEASE (2019)
sST2 Predicts Outcome in Chronic Heart Failure Beyond N-proBNP and High-Sensitivity Troponin T
Michele Emdin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
IL-33/ST2 Axis in Organ Fibrosis
Ourania S. Kotsiou et al.
FRONTIERS IN IMMUNOLOGY (2018)
IL-33 dysregulates regulatory T cells and impairs established immunologic tolerance in the lungs
Chien-Chang Chen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Wounds that heal and wounds that don't - The role of the IL-33/ST2 pathway in tissue repair and tumorigenesis
Neal L. Millar et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
The ST2/IL-33 Axis in immune Cells during inflammatory Diseases
Brad Griesenauer et al.
FRONTIERS IN IMMUNOLOGY (2017)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Clyde W. Yancy et al.
CIRCULATION (2017)
An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer
Charlotte O'Donnell et al.
BRITISH JOURNAL OF CANCER (2016)
Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure
W. H. Wilson Tang et al.
JACC-HEART FAILURE (2016)
The Biology of ST2: The International ST2 Consensus Panel
Domingo A. Pascual-Figal et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
The Prognostic Value of Plasma Soluble ST2 in Hospitalized Chinese Patients with Heart Failure
Rongcheng Zhang et al.
PLOS ONE (2014)
Soluble Concentrations of the Interleukin Receptor Family Member ST2 and ß-Blocker Therapy in Chronic Heart Failure
Hanna K. Gaggin et al.
CIRCULATION-HEART FAILURE (2013)
Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) study
Johan Lassus et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Soluble ST2 Serum Concentration and Renal Function in Heart Failure
Antoni Bayes-Genis et al.
JOURNAL OF CARDIAC FAILURE (2013)
Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology
Kaspar Broch et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
The Dual Function Cytokine IL-33 Interacts with the Transcription Factor NF-κB To Dampen NF-κB-Stimulated Gene Transcription
Shafaqat Ali et al.
JOURNAL OF IMMUNOLOGY (2011)
The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33
Gaby Palmer et al.
CYTOKINE (2008)
Biomarkers in heart failure
Eugene Braunwald
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel 'Alarmin'?
Christine Moussion et al.
PLOS ONE (2008)
Measurement of the interleukin family member ST2 in patients with acute dyspnea
James L. Januzzi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
Identification of serum soluble ST2 receptor as a novel heart failure biomarker
EO Weinberg et al.
CIRCULATION (2003)
分享论文
